galactosamine has been researched along with sb 216763 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Chen, Y; Duan, Z; Han, Y; Ma, Y; Piao, Z; Ren, F; Wen, T; Zhang, H; Zhang, J; Zheng, S; Zhou, L | 1 |
| Chen, D; Duan, Z; Li, Z; Ren, F; Shi, H; Wang, Z; Wen, T; Xie, B; Zhang, X; Zhou, L | 1 |
2 other study(ies) available for galactosamine and sb 216763
| Article | Year |
|---|---|
Inhibition of glycogen synthase kinase 3β ameliorates D-GalN/LPS-induced liver injury by reducing endoplasmic reticulum stress-triggered apoptosis.
Topics: Animals; Apoptosis; Caspase 12; Disease Models, Animal; Endoplasmic Reticulum Stress; Enzyme Activation; Enzyme Inhibitors; Galactosamine; Gene Expression Regulation; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Indoles; Lipopolysaccharides; Liver; Liver Failure, Acute; Male; Maleimides; Mice; Mitogen-Activated Protein Kinase Kinases; Signal Transduction; Toll-Like Receptor 4; Transaminases; Transcription Factor CHOP | 2012 |
Endoplasmic reticulum stress-activated glycogen synthase kinase 3β aggravates liver inflammation and hepatotoxicity in mice with acute liver failure.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Apoptosis; Aspartate Aminotransferases; Endoplasmic Reticulum Stress; Galactosamine; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hepatocytes; Indoles; Inflammation; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Liver; Liver Failure, Acute; Macrophages; Male; Maleimides; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Neutrophil Infiltration; NF-kappa B; Peroxidase; Phenylbutyrates; Tumor Necrosis Factor-alpha; Tunicamycin | 2015 |